The Effectiveness of Letrozole Alone or in Combination with Methotrexate in the Management of Ectopic Pregnancy, A Systematic Review and Meta-Analysis

Overview

Journal Reprod Sci

Publisher Springer

Specialty Reproductive Medicine

Date 2024 Oct 9

PMID 39384737

Authors

Azadeh Tarafdari

Fatemeh Keikha

Fatemeh Asadi

Sedigheh Hantoushzadeh

Omid Kohandel Gargari

Maryam Forouzin

Marjan Ghaemi

Affiliations

Soon will be listed here.

Abstract

This systematic review and meta-analysis aimed to investigate the effect of letrozole alone or in combination with Methotrexate on the management of ectopic pregnancy. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) were applied for reporting. The EMBASE, PubMed, Scopus, and Web of Science databases were searched for relevant studies focused on women diagnosed with ectopic pregnancy and managed non-surgically with letrozole alone or in combination with methotrexate (MTX) until April 2024. The success rate, laboratory findings, and complications were analyzed and reported. Meta-analysis was done using RevMan 5.4.1 software. Out of 129 unique studies obtained, 7 of them were found eligible for final review; of which, 3 were nonrandomized prospective cohort studies, 2 were randomized clinical trials, and 2 study were case studies. In 5 studies letrozole was used as monotherapy. While in another study letrozole was used with MTX. The meta-analysis showed a significantly lower level of β-HCG in the letrozole group compared to MTX, 7 days after initiation of treatment (Fixed effect model, MD = -92.22, 95%CI: [-159.39, -25.04], P = 0.007, I2 = 0%). There was no significant difference in the level of anti-mullerian hormone (AMH) between groups (Fixed effect model, MD = 0.18, 95%CI: [-0.09, 0.45], P = 0.20, I2 = 0%). Success rate, platelet count, and level of liver enzymes seemed to be better or similar among patients receiving Letrozole compared to patients receiving Methotrexate. Letrozole exhibits potential as a therapeutic option for ectopic pregnancies; however, further randomized clinical trials are necessary to establish strong evidence.

References

Sivalingam V, Duncan W, Kirk E, Shephard L, Horne A . Diagnosis and management of ectopic pregnancy. J Fam Plann Reprod Health Care. 2011; 37(4):231-40. PMC: 3213855. DOI: 10.1136/jfprhc-2011-0073. View

Bouyer J, Coste J, Fernandez H, Pouly J, Job-Spira N . Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod. 2002; 17(12):3224-30. DOI: 10.1093/humrep/17.12.3224. View

Garzon S, Lagana A, Pomini P, Raffaelli R, Ghezzi F, Franchi M . Laparoscopic reversible occlusion of uterine arteries and cornuostomy for advanced interstitial pregnancy. Minim Invasive Ther Allied Technol. 2018; 28(6):359-362. DOI: 10.1080/13645706.2018.1547764. View

Marion L, Meeks G . Ectopic pregnancy: History, incidence, epidemiology, and risk factors. Clin Obstet Gynecol. 2012; 55(2):376-86. DOI: 10.1097/GRF.0b013e3182516d7b. View

Lee R, Dupuis C, Chen B, Smith A, Kim Y . Diagnosing ectopic pregnancy in the emergency setting. Ultrasonography. 2017; 37(1):78-87. PMC: 5769947. DOI: 10.14366/usg.17044. View

van Mello N, Mol F, Ankum W, Mol B, van der Veen F, Hajenius P . Ectopic pregnancy: how the diagnostic and therapeutic management has changed. Fertil Steril. 2012; 98(5):1066-73. DOI: 10.1016/j.fertnstert.2012.09.040. View

Samal S, Rathod S . Cervical ectopic pregnancy. J Nat Sci Biol Med. 2015; 6(1):257-60. PMC: 4367055. DOI: 10.4103/0976-9668.149221. View

Rezaei Z, Ghaemi M, Feizabad E, Ghavami B, Akbari Asbagh F, Tanha F . The Effective Role of Adding Letrozole to Methotrexate in the Management of Tubal Ectopic Pregnancies, a Randomized Clinical Trial. Iran J Pharm Res. 2022; 20(4):378-384. PMC: 8842609. DOI: 10.22037/ijpr.2021.115659.15461. View

Alabiad M, Said W, Gad A, Sharaf ElDin M, Khairy D, Gobran M . Evaluation of Different Doses of the Aromatase Inhibitor Letrozole for the Treatment of Ectopic Pregnancy and Its Effect on Villous Trophoblastic Tissue. Reprod Sci. 2022; 29(10):2983-2994. PMC: 9537218. DOI: 10.1007/s43032-022-00993-0. View

10.

Mitwally M, Hozayen W, Hassanin K, Abdalla K, Abdalla N . Aromatase inhibitor letrozole: a novel treatment for ectopic pregnancy. Fertil Steril. 2020; 114(2):361-366. DOI: 10.1016/j.fertnstert.2020.04.001. View

11.

Garcia-Velasco J, Moreno L, Pacheco A, Guillen A, Duque L, Requena A . The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril. 2005; 84(1):82-7. DOI: 10.1016/j.fertnstert.2005.01.117. View

12.

Gurates B, Parmaksiz C, Kilic G, Celik H, Kumru S, Simsek M . Treatment of symptomatic uterine leiomyoma with letrozole. Reprod Biomed Online. 2008; 17(4):569-74. DOI: 10.1016/s1472-6483(10)60246-5. View

13.

Kashani B, Centini G, Morelli S, Weiss G, Petraglia F . Role of Medical Management for Uterine Leiomyomas. Best Pract Res Clin Obstet Gynaecol. 2016; 34:85-103. DOI: 10.1016/j.bpobgyn.2015.11.016. View

14.

Nash C, Philp L, Shah P, Murphy K . Letrozole pretreatment prior to medical termination of pregnancy: a systematic review. Contraception. 2017; 97(6):504-509. DOI: 10.1016/j.contraception.2017.11.003. View

15.

Zhuo Y, Cainuo S, Chen Y, Sun B . The efficacy of letrozole supplementation for medical abortion: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2019; 34(9):1501-1507. DOI: 10.1080/14767058.2019.1638899. View

16.

Palomba S . Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab. 2015; 100(5):1742-7. DOI: 10.1210/jc.2014-4235. View

17.

Moons K, de Groot J, Bouwmeester W, Vergouwe Y, Mallett S, Altman D . Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014; 11(10):e1001744. PMC: 4196729. DOI: 10.1371/journal.pmed.1001744. View

18.

Shi J, Luo D, Weng H, Zeng X, Lin L, Chu H . Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods. 2020; 11(5):641-654. DOI: 10.1002/jrsm.1429. View

19.

Luo D, Wan X, Liu J, Tong T . Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2016; 27(6):1785-1805. DOI: 10.1177/0962280216669183. View

20.

Wan X, Wang W, Liu J, Tong T . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014; 14:135. PMC: 4383202. DOI: 10.1186/1471-2288-14-135. View